Literature DB >> 15892652

Insulin resistance in type 2 diabetes -- role of the adipokines.

P Arner1.   

Abstract

The role of adipocytes as protein secreting cells has been known for almost 15 years. Most of these proteins have known biological activity and are called adipokines. However, only a few of the adipokines have been shown to regulate insulin sensitivity. The latter effects are direct or indirect. The adipokines regulating insulin sensitivity are tumor necrosis factor alpha, adiponectin, interleukin-6, resistin and leptin. This review examines the mechanism how these adipokines influence insulin sensitivity, how the adipocyte production of the adipokines is regulated and if genetic variance in the genes encoding for adipokines is important for the development of type 2 diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15892652     DOI: 10.2174/1566524053766022

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  46 in total

Review 1.  Resistin: yet another adipokine tells us that men are not mice.

Authors:  P Arner
Journal:  Diabetologia       Date:  2005-11       Impact factor: 10.122

2.  Conjugated linoleic acid down-regulates expression of resistin and adiponectin in fully differentiated 3T3-F442A cells.

Authors:  Efrat Forti; Ruth Z Birk
Journal:  Genes Nutr       Date:  2007-10       Impact factor: 5.523

3.  Adaptive metabolic response to 4 weeks of sugar-sweetened beverage consumption in healthy, lightly active individuals and chronic high glucose availability in primary human myotubes.

Authors:  Francesco Sartor; Matthew J Jackson; Cesare Squillace; Anthony Shepherd; Jonathan P Moore; Donald E Ayer; Hans-Peter Kubis
Journal:  Eur J Nutr       Date:  2012-06-26       Impact factor: 5.614

4.  High levels of Zinc-α-2-Glycoprotein among Omani AIDS patients on combined antiretroviral therapy.

Authors:  Sidgi Syed Anwer Hasson; Mohammed Saeed Al-Balushi; Muzna Hamed Al Yahmadi; Juma Zaid Al-Busaidi; Elias Antony Said; Mohammed Shafeeq Othman; Talal Abdullah Sallam; Mohammed Ahmad Idris; Ali Abdullah Al-Jabri
Journal:  Asian Pac J Trop Biomed       Date:  2014-08

5.  Impact of reduced meal frequency without caloric restriction on glucose regulation in healthy, normal-weight middle-aged men and women.

Authors:  Olga Carlson; Bronwen Martin; Kim S Stote; Erin Golden; Stuart Maudsley; Samer S Najjar; Luigi Ferrucci; Donald K Ingram; Dan L Longo; William V Rumpler; David J Baer; Josephine Egan; Mark P Mattson
Journal:  Metabolism       Date:  2007-12       Impact factor: 8.694

6.  Adipocytokines as features of the metabolic syndrome determined using confirmatory factor analysis.

Authors:  Mark M Smits; Pier Woudstra; Kristina M Utzschneider; Jenny Tong; Fernando Gerchman; Mirjam Faulenbach; Darcy B Carr; Kathryn Aston-Mourney; Alan Chait; Robert H Knopp; James B Meigs; Edward J Boyko; Steven E Kahn
Journal:  Ann Epidemiol       Date:  2013-03-25       Impact factor: 3.797

7.  Effects of high-dose isoflavones on metabolic and inflammatory markers in healthy postmenopausal women.

Authors:  Cornelia Charles; Julia Yuskavage; Olga Carlson; Majnu John; Arlene S Tagalicud; Marcello Maggio; Denis C Muller; Josephine Egan; Shehzad Basaria
Journal:  Menopause       Date:  2009 Mar-Apr       Impact factor: 2.953

8.  Effects of short-term corticoid ingestion on food intake and adipokines in healthy recreationally trained men.

Authors:  N Rieth; L Jollin; B Le Panse; A-M Lecoq; A Arlettaz; J De Ceaurriz; K Collomp
Journal:  Eur J Appl Physiol       Date:  2008-11-05       Impact factor: 3.078

9.  A variation in the cerebroside sulfotransferase gene is linked to exercise-modified insulin resistance and to type 2 diabetes.

Authors:  A Roeske-Nielsen; K Buschard; J E Månson; L Rastam; U Lindblad
Journal:  Exp Diabetes Res       Date:  2009-07-05

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.